Search
for
Sort by
Research 811–840 of 1000+
- Central nervous system demyelination associated with tofacitinib use in alopecia areata: A case report and literature review
- Common Skin Diseases and Metabolic Syndrome: A Proinflammatory Chemokine Perspective
- 0480 Upadacitinib monotherapy for treatment of pyoderma gangrenosum: A case series
- Efficacy and Safety of Topical Tofacitinib for the Treatment of Alopecia Areata
- LB1667 Successful treatment of rare linear lichen planopilaris with ixekizumab
- New Topical Treatment for Psoriasis
- 877 Loss of UBE2N in keratinocytes leads to skin inflammation and immune infiltration through IRAK1/4-mediated processes
- 1326 Translation-dependent skin hyperplasia is promoted by type 1/17 inflammation in psoriasis
- Successful treatment of rare linear lichen planopilaris with Ixekizumab
- Combination of topical anthralin and calcipotriene in alopecia areata: A discussion of the mechanisms of action
- 083 More Expression of IL-17 than IFN-γ from CD49a-negative Tissue-Resident Memory T (Trm) cells at the Hair Bulge and Hair Bulb Region in the Scalp of Chronic Alopecia Areata Patients according to the Foxp3+mTregs depletion
- Contents
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- The use of cyclosporine in dermatology: Part I
- Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients
- Videodermoscopy of the hyponychium in nail bed psoriasis
- Recurrence of Alopecia Areata in a Patient Receiving Etanercept Injections
- Topical tretinoin for hair growth promotion
- Dermal Delivery of Topically Applied Oligonucleotides via Follicular Transport in Mouse Skin
- The RAIG Family Member, GPRC5D, Is Associated with Hard-Keratinized Structures
- Oxidative Stress in Alopecia Areata: A Case–Control Study
- Sulfasalazine for alopecia areata
- Soluble factors from human hair papilla cells and dermal fibroblasts dramatically increase the clonal growth of outer root sheath cells
- Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?
- Loss of epidermal Evi/Wls results in a phenotype resembling psoriasiform dermatitis
- The imbalance between Type 17 T-cells and regulatory immune cell subsets in psoriasis vulgaris
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- Mycobacterial 65,000 MW heat-shock protein shares a carboxy-terminal epitope with human epidermal cytokeratin 1/2.
- Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine